# A Study in Patients With Advanced Breast Cancer

> **NCT04942054** · PHASE1 · TERMINATED · sponsor: **Sun Pharma Advanced Research Company Limited** · enrollment: 9 (actual)

## Conditions studied

- HER2-negative Breast Cancer
- Advanced Breast Cancer
- Hormone Receptor-positive Breast Cancer

## Interventions

- **DRUG:** Part 1
- **DRUG:** Part 2
- **DRUG:** Part 3

## Key facts

- **NCT ID:** NCT04942054
- **Lead sponsor:** Sun Pharma Advanced Research Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-05-20
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-02-28
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** The decision to close is due commercial reasons only
- **Last updated:** 2023-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04942054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04942054, "A Study in Patients With Advanced Breast Cancer". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT04942054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*